《大行報告》大摩下調百威亞太(01876.HK)目標價至28元 評級「增持」
大摩發表評級報告,將百威亞太(01876.HK)在2023年至25年的各年每股盈測分別下調9%、7%及7%,同時預料銷售增長分別達9%、10%及8%,而息稅折舊及攤銷前利潤(EBITDA)分別增長12%、14%及12%。
該行表示,將全年銷售預測下調4%,主要是韓國消費情緒疲弱,降低對亞太區東部的預期;同時,該行將公司營運利潤率預測下調140個基點,毛利率則下調170個基點。
該行將百威亞太目標價由30元下調至28元,維持其評級為「增持」。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.